CMTM6 and glioblastoma: Our results indicated that high CMTM6 expression was associated with poor clinical prognosis in ACC, GBM, LAML, LIHC, MESO, SARC, THYM, and UVM and that CMTM6 may play a promoting role in tumor progression.